Rafina Innovations Inc. is a company that develops, researches, commercializes, and markets medical technologies. Its operations are divided into two main areas: its Clinic division and its Technology division. The company manages specialized rehabilitation clinics for prosthetics, orthotics, and comprehensive diabetic foot care, serving patients in Southern Europe, the Middle East, and North Africa. Within its Technology arm, Rafina Innovations Inc. is actively engaged in the creation, development, and market introduction of medical devices, innovative methods, and products. This work covers a broad range of fields, including but not limited to, prosthetics, orthotics, general rehabilitation, bioengineering, mobility, diabetes and diabetic foot care, tissue mechanics, ultrasonics, medical signal processing and analysis, general medical technology, orthopedics, and robotic surgery. Additionally, the company licenses its proprietary technological advancements. Founded in 2007, the company changed its name from HCi Viocare to Rafina Innovations Inc. in July 2018. Its base of operations is in Glasgow, United Kingdom.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Rafina Innovations stocks are traded under the ticker HCF.STU.
What is Rafina Innovations revenue for the last year?▼
Rafina Innovations revenue for the last year amounts to 2.79M EUR.
What is Rafina Innovations net income for the last year?▼
HCF.STU net income for the last year is -753,250.16 EUR.
How many employees does Rafina Innovations have?▼
As of September 04, 2026, the company has 4 employees.
In which sector is Rafina Innovations located?▼
Rafina Innovations operates in the Health & Wellness sector.
When did Rafina Innovations complete a stock split?▼
The last stock split for Rafina Innovations was on July 09, 2018 with a ratio of 1:20.
Where is Rafina Innovations headquartered?▼
Rafina Innovations is headquartered in Glasgow, United States.